Nicklas Westerholm
Chief Executive Officer chez EGETIS THERAPEUTICS AB
Fortune : 123 465 $ au 31/03/2024
Profil
Mr. Nicklas Westerholm is an Independent Director at Spago Nanomedical AB, a Chief Executive Officer at Egetis Therapeutics AB and a Chairman & Chief Executive Officer at Rare Thyroid Therapeutics International AB.
He is on the Board of Directors at Spago Nanomedical AB.
Mr. Westerholm was previously employed as a Vice President by AstraZeneca AB and an Investor Relations Contact by AstraZeneca PLC.
He received his undergraduate degree from the University of Stockholm and an undergraduate degree from Royal Institute of Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EGETIS THERAPEUTICS AB
0,07% | 31/12/2022 | 197 629 ( 0,07% ) | 123 465 $ | 31/03/2024 |
Postes actifs de Nicklas Westerholm
| Sociétés | Poste | Début |
|---|---|---|
| EGETIS THERAPEUTICS AB | Chief Executive Officer | 16/06/2017 |
| SPAGO NANOMEDICAL AB | Director/Board Member | 08/05/2019 |
Rare Thyroid Therapeutics International AB
 Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Rare Thyroid Therapeutics International AB provides thyroid therapeutics research services. The company is headquartered in Stockholm, Sweden. | Chief Executive Officer | - |
Anciens postes connus de Nicklas Westerholm
| Sociétés | Poste | Fin |
|---|---|---|
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | 01/06/2017 |
| ASTRAZENECA PLC | Investor Relations Contact | 08/09/2011 |
Formation de Nicklas Westerholm
| University of Stockholm | Undergraduate Degree |
| Royal Institute of Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| EGETIS THERAPEUTICS AB | Health Technology |
| SPAGO NANOMEDICAL AB | Health Technology |
| Entreprise privées | 2 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Rare Thyroid Therapeutics International AB
Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Rare Thyroid Therapeutics International AB provides thyroid therapeutics research services. The company is headquartered in Stockholm, Sweden. | Health Technology |
